The LIVER Act is a public health initiative that will help people of all ages, lifestyles, and ethnic backgrounds reduce their risk for liver cancer and related risk factors like viral hepatitis and NASH.

This survey is designed to collect information about your priorities and preferences for addressing NASH. Data from this survey will be used by Global Liver Institute, a 501(c)3 patient advocacy and support organization, for research in our mission to help develop potential treatments for NASH. This information will also be shared with the U.S. Food and Drug Administration, and a variety of other stakeholders within the medical community to help them understand your thoughts and feelings about potential treatments for NASH.

TROA would expand Medicare coverage to include screening and treatment of obesity from a diverse range of healthcare providers who specialize in obesity care.